117 results on '"Mari, Andrea"'
Search Results
2. MP67-07 RISKS AND BENEFITS OF PARTIAL NEPHRECTOMY WITH LIMITED OR WITHOUT ISCHEMIA TIME IN THE EXTREME SCENARIO OF PATIENTS WITH A SOLITARY KIDNEY
3. PD11-08 USAGE OF 3D VIRTUAL MODELS TO MAXIMIZE THE ACCURACY OF NEPHROMETRIC SCORES IN DETERMINING THE SURGICAL COMPLEXITY OF RENAL MASSES FIT FOR RAPN: RESULTS FROM A PROSPECTIVE MULTICENTER INTERNATIONAL ERUS VALIDATION STUDY
4. PD34-12 THE OPTIMAL NUMBER OF INDUCTION CHEMOTHERAPY CYCLES IN CLINICALLY LYMPH NODE-POSITIVE BLADDER CANCER
5. MP38-20 RISK OF UPPER URINARY TRACT DISSEMINATION IN cT3 BLADDER CANCER PATIENTS TREATED WITH DOUBLE-J STENT VERSUS NEPHROSTOMY TUBE PRIOR TO RADICAL CYSTECTOMY
6. MP56-08 A NOVEL URODYNAMIC SCORING SYSTEM TO ASSESS CONTINENCE QUALITY OUTCOMES OF ILEAL ORTHOTOPIC NEOBLADDERS
7. PD07-03 UNVEIL THE INTERPLAY BETWEEN BASELINE RENAL FUNCTION, WARM ISCHEMIA TIME AND TUMOR COMPLEXITY WHEN ASSESSING RENAL FUNCTIONAL OUTCOMES OF ON- VS OFF-CLAMP ROBOT-ASSISTED PARTIAL NEPHRECTOMY
8. PD07-02 DEVELOPMENT AND INTERNAL VALIDATION OF A NOMOGRAM TO PREDICT FIVE-YEARS SIGNIFICANT CKD UPSTAGING AFTER ROBOT-ASSISTED PARTIAL NEPHRECTOMY
9. PD09-03 INVERSE PROBABILITY TREATMENT WEIGHTING COMPARISON OF RADICAL CYSTECTOMY TO TRIMODALITY THERAPY FOR CT2-CT4 MUSCLE INVASIVE BLADDER CANCER
10. MP46-19 THE ROLE OF EXTENDED VERSUS STANDARD LYMPHADENECTOMY LYMPH NODE DISSECTION IN CLINICALLY LYMPH NODE-POSITIVE BLADDER CANCER
11. PD07-07 NEPHROMETRY ADJUSTED COMPARISON OF PERIOPERATIVE AND FUNCTIONAL OUTCOMES BETWEEN ON CLAMP VS OFF-CLAMP ROBOT-ASSISTED PARTIAL NEPHRECTOMY
12. PD13-09 CLINICAL VALIDATION OF THE EAU2021 INTERMEDIATE RISK NMIBC DEFINITION AND IMPLICATIONS FOR ADJUVANT TREATMENT: A MULTICENTER YAU UROTHELIAL COLLABORATION
13. PD40-12 FUNCTIONAL OUTCOMES PREDICTION AFTER ROBOTIC PARTIAL NEPHRECTOMY USING PADUA SCORE ASSESSED WITH 3D VIRTUAL MODELS: PRELIMINARY RESULTS OF A COLLABORATIVE ERUS STUDY
14. PD07-05 ASSESSING THE TRADE-OFF BETWEEN SAFETY AND EFFECTIVENESS OF OFF-CLAMP ROBOTIC PARTIAL NEPHRECTOMY IN PATIENTS WITH HIGH RENAL SCORE: A PROPENSITY SCORE-MATCHED COMPARISON OF PERIOPERATIVE AND FUNCTIONAL OUTCOMES IN A MULTICENTER ANALYSIS
15. Diagnostic Accuracy of Clinical Lymph Node Staging for Upper Tract Urothelial Cancer Patients: A Multicenter, Retrospective, Observational Study
16. MP23-15 IMPACT OF PREVIOUS TREATMENTS FOR PROSTATE CANCER ON PERIOPERATIVE AND ONCOLOGICAL OUTCOMES IN PATIENTS TREATED WITH RADICAL CYSTECTOMY FOR BLADDER CANCER
17. PD17-04 PROSTATE CANCERS DETECTED AT MULTI-PARAMETRIC MRI TARGETED VERSUS SYSTEMATIC BIOPSIES: ARE THEY EQUAL? RESULTS FROM A LARGE MULTI-INSTITUTIONAL SERIES
18. MP54-16 IMMEDIATE RADICAL CYSTECTOMY VS. BCG IMMUNOTHERAPY FOR T1 HIGH GRADE NON-MUSCLE-INVASIVE BLADDER CANCER: AN INTERNATIONAL MULTICENTRE COLLABORATION
19. PD42-01 PROPENSITY MATCHED COMPARISON OF RADICAL CYSTECTOMY WITH TRIMODALITY THERAPY FOR MUSCLE INVASIVE BLADDER CANCER (MIBC): A MULTI-INSTITUTIONAL STUDY
20. PD18-06 NEPHROMETRY SCORES PREDICTING VALUE OF TRIFECTA ACHIEVEMENT IN A MULTICENTER ANALYSIS (ROSULA DATABASE) OF ROBOTIC PARTIAL NEPHRECTOMY FOR TOTALLY ENDOPHYTIC DEEP RENAL MASSES
21. MP41-06 A PROSPECTIVE, RANDOMIZED, MULTI-CENTRE TRIAL ON THE EFFICIENCY AND EFFECTIVENESS OF PROFICIENCY BASED PROGRESSION ROBOTIC SURGICAL SKILLS TRAINING
22. MP51-07 THE PROGNOSTIC VALUE OF THE NUMBER OF POSITIVE TARGETED CORES IN MEN WITH POSITIVE MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING OF THE PROSTATE. RESULTS FROM A LARGE, MULTI-INSTITUTIONAL SERIES
23. MP24-20 ANALYSIS OF PREDICTORS OF sCKD PROGRESSION AFTER MINIMALLY-INVASIVE IMPERATIVE PARTIAL NEPHRECTOMY IN PATIENTS WITH PREOPERATIVE CKD STAGE 3A: RESULTS OF A MULTI-INSTITUTIONAL COLLABORATIVE SERIES
24. MP24-12 RISKS ASSESSMENT OF SIGNIFICANT RENAL FUNCTION DETERIORATION AFTER PARTIAL NEPHRECTOMY AND CALL FOR RECONSIDERING THE IMPERATIVE SETTING
25. MP40-11 RENAL FUNCTION VARIATION AFTER NEPHROURETERECTOMY FOR UPPER URINARY TRACT CARCINOMA: EVALUATION IN A LARGE MULTICENTER COHORT (RADICAL NEPHROURETERECTOMY OUTCOMES (RANEO) RESEARCH CONSORTIUM)
26. MP53-20 ADDED VALUE OF MPMRI IN THE STRATIFICATION OF PATIENTS WITH HIGH-RISK PATIENTS PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY: IMPLICATIONS FOR TAILORED MULTI-MODAL STRATEGIES
27. MP41-13 DOES QUALITY ASSURED ELEARNING PROVIDE ADEQUATE PREPARATION FOR ROBOTIC SURGICAL SKILLS; A PROSPECTIVE, RANDOMIZED AND MULTI-CENTER STUDY
28. MP50-16 ASSESSING THE ROLE OF OFF-CLAMP ROBOTIC PARTIAL NEPHRECTOMY IN THE SETTING OF LOW COMPLEXITY RENAL TUMORS: PROPENSITY SCORE-MATCHED ANALYSIS OF A MULTICENTER DATABASE
29. The Association between Income Status and Treatment Selection for Prostate Cancer in a Universal Health Care System: A Population-Based Analysis. Letter.
30. MP48-17 URETERAL STENTING DOES NOT INCREASE THE RISK OF METACHRONOUS UPPER TRACT UROTHELIAL CARCINOMA IN PATIENTS WITH BLADDER CANCER PRESENTING WITH HYDRONEPHROSIS IN COMPARISON WITH PERCUTANEOUS NEPHROSTOMY
31. MP59-01 RENAL FUNCTION DETERIORATION ASSESSMENT IN TOTALLY ENDOPHYTIC DEEP RENAL MASSES TREATED WITH ROBOTIC PARTIAL NEPHRECTOMY: COMPARISON WITH A WHOLE COHORT OF CT1-2 RENAL TUMORS PATIENTS FROM A MULTICENTER ANALYSIS (ROSULA DATABASE)
32. MP59-02 PURELY-OFF CLAMP VS ON-CLAMP IMPERATIVE MINIMALLY-INVASIVE PARTIAL NEPHRECTOMY: RESULTS OF A MULTI-INSTITUTIONAL COLLABORATIVE SERIES
33. MP11-09 ADDED VALUE OF RADIOLOGICAL TUMOR STAGE IN PREDICTING EARLY ONCOLOGICAL OUTCOMES IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY WITHIN CLINICAL STAGE: A STAGE-BY-STAGE ANALYSIS
34. MP05-16 WHAT IS THE DEFINITION OF MISCLASSIFICATION IN PATIENTS WITH GRADE GROUP 2 PROSTATE CANCER ELIGIBLE FOR ACTIVE SURVEILLANCE AND DIAGNOSED WITH MRI TARGETED BIOPSY? A MULTI-INSTITUTIONAL ANALYSIS WITH PATHOLOGICAL CONFIRMATION
35. PD57-08 INDIVIDUALIZED RISK STRATICATION OF PATIENTS CANDIDATE TO RADICAL PROSTATECTOMY BASED ON CLINICAL AND MULTI-PARAMETRIC MRI PARAMETERS: BEYOND THE CONVENTIONAL CLINICAL RISK MODELS
36. MP16-18 SURVIVAL OUTCOMES AFTER RADICAL CYSTECTOMY VERSUS CONSERVATIVE MANAGEMENT FOR T1 HIGH GRADE NON-MUSCLE INVASIVE MICROPAPILLARY BLADDER CANCER: A MULTICENTER COLLABORATION BY THE EUROPEAN ASSOCIATION OF UROLOGY - YOUNG ACADEMIC UROLOGISTS
37. MP49-15 ROBOTIC PARTIAL NEPHRECTOMY FOR TOTALLY ENDOPHYTIC DEEP RENAL MASSES: PERIOPERATIVE, PATHOLOGIC, ONCOLOGIC AND FUNCTIONAL OUTCOMES OF A MULTICENTER ANALYSIS (ROSULA DATABASE)
38. MP59-16 SHIFTING FROM PLANNED OFF-CLAMP TO ON-CLAMP APPROACH DURING PARTIAL NEPHRECTOMY: CROSS-ANALYSIS OF TWO RANDOMIZED TRIALS
39. MP59-09 TRIFECTA ASSESSMENT IN TOTALLY ENDOPHYTIC DEEP RENAL MASSES TREATED WITH ROBOTIC PARTIAL NEPHRECTOMY: COMPARISON WITH A WHOLE COHORT OF cT1-2 RENAL TUMORS PATIENTS FROM A MULTICENTER ANALYSIS (ROSULA DATABASE)
40. Risk Factors for Intravesical Recurrence after Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Cancer (ROBUUST Collaboration)
41. PD55-08 SELECTING THE BEST CANDIDATES FOR CISPLATIN-BASED ADJUVANT CHEMOTHERAPY AFTER RADICAL CYSTECTOMY IN PN+ BLADDER CANCER PATIENTS
42. PD65-07 LIFESTYLE MODIFICATIONS AND THEIR EFFECT ON SERUM PROSTATE SPECIFIC ANTIGEN LEVELS
43. MP59-08 ASSESSING PREDICTORS OF CHRONIC KIDNEY DISEASE PROGRESSION IN PATIENTS RECEIVING MINIMALLY-INVASIVE PARTIAL NEPHRECTOMY: RESULTS OF A MULTI-INSTITUTIONAL COLLABORATIVE SERIES
44. Deviation from the Protocol of a Randomized Clinical Trial Comparing On-Clamp versus Off-Clamp Laparoscopic Partial Nephrectomy (CLOCK II Laparoscopic Study): A Real-Life Analysis
45. Reply by Authors
46. MP57-09 COMBINED ASSESSMENT OF LONG-TERM FUNCTIONAL AND ONCOLOGIC OUTCOMES AFTER ROBOT-ASSISTED PARTIAL NEPHRECTOMY: THE ROME'S SCORE
47. MP82-06 NEW CLASSIFICATION FOR UPPER TRACT UROTHELIAL CARCINOMA TO ENHANCE RISK STRATIFICATION OF PATIENTS ELIGIBLE TO ENDOSCOPIC MANAGEMENT: AN INTERNATIONAL COLLABORATIVE STUDY
48. MP21-20 THE IMPACT OF ISCHEMIA ON CHRONIC KIDNEY DISEASE PROGRESSION AFTER ROBOTIC PARTIAL NEPHRECTOMY IN PATIENTS OVER 75 YEARS OLD: RESULTS OF A MULTI-INSTITUTIONAL COLLABORATIVE SERIES (ROSULA)
49. MP73-01 SEQUENTIAL ADMINISTRATION OF BACILLUS CALMETTE-GUERIN (BCG) AND ELECTROMOTIVE DRUG ADMINISTRATION (EMDA) OF MITOMYCIN C (MMC) FOR THE TREATMENT OF HIGH GRADE NON MUSCLE INVASIVE BLADDER CANCER AFTER BCG FAILURE
50. MP57-08 DEVELOPMENT OF A NOMOGRAM TO PREDICT ACHIEVEMENT OF TRIFECTA OUTCOMES AFTER ROBOTIC PARTIAL NEPHRECTOMY FOR CT1-2 RENAL TUMORS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.